HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Donna Karan

This article was originally published in The Rose Sheet

Executive Summary

Donna Karan: Extending the Donna Karan New York Bath & Body line with DK naturals. The products use the same formulas as the original line, according to the company. Made with natural ingredients including moisturizing Plantel Blosomes EFA, a naturally derived plant oil exclusive to the company, the original line bowed in July 1994 ("The Rose Sheet" May 30, 1994, p. 4). Taking "a fashion approach to bath products," the company has packaged the four-SKU line in "a pale, neutral exterior to suit light toned vanities and decors," the company says. The naturals line comprises a 6.7 oz. Cashmere Body Lotion and Washed Silk Body Cleansing Lotion, a 5 oz. Velvet Body Cream and a 4 oz. Chiffon Body Powder. Prices range from $35 for the powder and cleansing lotion to $65 for the body cream...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel